UK Transfusion Diagnostics Market 2021: Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Technology and Instrumentation
Complete report $6,100. DataPack (test volumes, sales forecasts, supplier shares) $3,950.
This comprehensive report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the UK transfusion diagnostic market during the next five years, and assist industry executives in developing effective business, new product development and marketing strategies. The report explores future marketing and technological trends in UK; provides test volume and sales forecasts by market segment/test location; compares features of major automated and semi-automated analyzers; profiles leading and emerging competitors; and identifies specific product and market opportunities facing suppliers during the next five years.
Blood Typing and Grouping Tests
ABO, Antibody Panels, Antibody Screening/Indirect Antiglobulin, Antigen Typing (C, c, Duffy, E, e, I, i, Kell, Kidd, Le a, b, MN, P, S, s), Antiglobulin (Direct, C3 + IgG, IgG, C3), Crossmatching (Immediate Spin, Full Crossmatch), Rh (D, Du).Infectious Disease Screening TestsAIDS (HIV NAT, HIV-1/2), Cytomegalovirus, Hepatitis (HAV NAT, HBV NAT, HBs Ag, Anti-HBc, HCV NAT, HCV, ALT/SGPT), HTLV-I/II, Parvovirus B19 NAT, Syphilis, West Nile Virus NAT.
Sales and Market Share Analysis
Sales and market share estimates for leading suppliersof transfusion diagnostic products by individual product.
Competitive Assessments
Strategic assessments of major suppliers and emerging market entrants, including their sales,product portfolios, marketing tactics, and new products in R&D.
Market Segmentation Analysis
Assessment of current and emergingtechnologies, and their potential applicationsfor the transfusion diagnostics market.- Comprehensive lists of companies developingor marketing new technologies and products, by test.
Strategic Recommendations
New product development opportunitieswith significant market appeal.- Alternative market penetration strategies.- Potential market entry barriers and risks.
Contains 422 pages and 39 tables
This comprehensive report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the UK transfusion diagnostic market during the next five years, and assist industry executives in developing effective business, new product development and marketing strategies. The report explores future marketing and technological trends in UK; provides test volume and sales forecasts by market segment/test location; compares features of major automated and semi-automated analyzers; profiles leading and emerging competitors; and identifies specific product and market opportunities facing suppliers during the next five years.
Blood Typing and Grouping Tests
ABO, Antibody Panels, Antibody Screening/Indirect Antiglobulin, Antigen Typing (C, c, Duffy, E, e, I, i, Kell, Kidd, Le a, b, MN, P, S, s), Antiglobulin (Direct, C3 + IgG, IgG, C3), Crossmatching (Immediate Spin, Full Crossmatch), Rh (D, Du).Infectious Disease Screening TestsAIDS (HIV NAT, HIV-1/2), Cytomegalovirus, Hepatitis (HAV NAT, HBV NAT, HBs Ag, Anti-HBc, HCV NAT, HCV, ALT/SGPT), HTLV-I/II, Parvovirus B19 NAT, Syphilis, West Nile Virus NAT.
Sales and Market Share Analysis
Sales and market share estimates for leading suppliersof transfusion diagnostic products by individual product.
Competitive Assessments
Strategic assessments of major suppliers and emerging market entrants, including their sales,product portfolios, marketing tactics, and new products in R&D.
Market Segmentation Analysis
- Comprehensive market segmentationanalysis, including review of the marketdynamics, trends, structure, size, growth,and key suppliers.
- Test volume and sales forecasts for over 40 blood typing, grouping and infectious disease screening tests,including NAT, by country and market segment:
- Blood Centers
- Hospitals
- Commercial/Private Laboratories
- Analysis of current and emerging blood typing, grouping and infectious disease screening tests.
- Review of automated and semi-automated analyzers.
Assessment of current and emergingtechnologies, and their potential applicationsfor the transfusion diagnostics market.- Comprehensive lists of companies developingor marketing new technologies and products, by test.
Strategic Recommendations
New product development opportunitieswith significant market appeal.- Alternative market penetration strategies.- Potential market entry barriers and risks.
Contains 422 pages and 39 tables
I. INTRODUCTION
II. MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES
A. Blood Typing and Grouping
B. Infectious Disease Screening
C. Auxiliary
III. ALTERNATIVE MARKET PENETRATION STRATEGIES
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
IV. POTENTIAL MARKET ENTRY BARRIERS AND RISKS
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
V. Worldwide Technology and Market Overview
A.Major Blood Typing, Grouping and Infectious Disease Screening Tests
1. BLOOD TYPING AND GROUPING TESTS
a. ABO
b. Antibody Panels
c. Antibody Screening
d. Antigen Typing
e. Antiglobulin Test
f. Crossmatch
g. HLA Typing
h. Rh
i. Other Blood Groups
2. INFECTIOUS DISEASE SCREENING TESTS
a. AIDS/HIV
Background
Diagnostic Tests
Enzyme Immunoassay
Viral Load/Drug Resistance Testing
Genotype and Phenotype Testing
Blood Banking Considerations
b. Hepatitis Markers
Hepatitis A
Hepatitis B
Hepatitis C
Hepatitis D (Delta Hepatitis)
Hepatitis E
Hepatitis G
Vaccines and Drugs
c. Cytomegalovirus
Background
Diagnostic Tests
Vaccines and Drugs
d. Syphilis
Background
Diagnostic Tests
Vaccines and Drugs
e. West Nile Virus
Background
Clinical Syndromes
Diagnostic Tests
Vaccines and Drugs
f. Parvovirus B19
Microbiology
Epidemiology
Clinical Syndromes
Diagnostic Test
Vaccines and Drugs
g. Creutzfeldt-Jakob’s Disease
Background
Transmission
Diagnostic Tests
Vaccines and Drugs
h. Malaria
i. Chagas Disease
j. Babesiosis
3. PATHOGEN REDUCTION
4. LEUKOCYTE REDUCTION
Background
Methods
B. Instrumentation Review: Operating Characteristics, Features and Selling Prices of Leading Blood Typing, Grouping and Infectious Disease Screening Automated and Semiautomated Analyzers
C.Major Blood Banking Technologies and Their Potential Applications
1. MOLECULAR DIAGNOSTICS
2. MONOCLONAL AND POLYCLONAL ANTIBODIES
3. IMMUNOASSAYS
4. MICROTITRATION PLATES
5. IT AND AUTOMATION
6. LASERS
7. ROBOTICS
8. SYNTHETIC RED CELL SUBSTITUTES
9. GENETICALLY ENGINEERED BLOOD COMPONENTS
10. BLOOD PRESERVATION
11. AUTOLOGOUS BLOOD TRANSFUSION/FREEZING
VI. UK Blood Banking Market
A. EXECUTIVE SUMMARY
B. Business Environment
C. Market Structure
D. Market Size, Test Volume and Sales Forecasts, by Market Segment,Major Supplier Sales and Market Shares
VII. Competitive Assessments
Abbott
Beckman Coulter/Danaher
Becton Dickinson
Biokit
BioMerieux
Bio-Rad
CellMark Forensics/LabCorp
Diagast
DiaSorin
Fujirebio
Hologic/Gen-Probe
Grifols
Immucor
Ortho-Clinical Diagnostics
Proteome Sciences
Quest Diagnostics
Quidel
Roche
Siemens
Tecan
II. MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES
A. Blood Typing and Grouping
B. Infectious Disease Screening
C. Auxiliary
III. ALTERNATIVE MARKET PENETRATION STRATEGIES
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
IV. POTENTIAL MARKET ENTRY BARRIERS AND RISKS
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
V. Worldwide Technology and Market Overview
A.Major Blood Typing, Grouping and Infectious Disease Screening Tests
1. BLOOD TYPING AND GROUPING TESTS
a. ABO
b. Antibody Panels
c. Antibody Screening
d. Antigen Typing
e. Antiglobulin Test
f. Crossmatch
g. HLA Typing
h. Rh
i. Other Blood Groups
2. INFECTIOUS DISEASE SCREENING TESTS
a. AIDS/HIV
Background
Diagnostic Tests
Enzyme Immunoassay
Viral Load/Drug Resistance Testing
Genotype and Phenotype Testing
Blood Banking Considerations
b. Hepatitis Markers
Hepatitis A
Hepatitis B
Hepatitis C
Hepatitis D (Delta Hepatitis)
Hepatitis E
Hepatitis G
Vaccines and Drugs
c. Cytomegalovirus
Background
Diagnostic Tests
Vaccines and Drugs
d. Syphilis
Background
Diagnostic Tests
Vaccines and Drugs
e. West Nile Virus
Background
Clinical Syndromes
Diagnostic Tests
Vaccines and Drugs
f. Parvovirus B19
Microbiology
Epidemiology
Clinical Syndromes
Diagnostic Test
Vaccines and Drugs
g. Creutzfeldt-Jakob’s Disease
Background
Transmission
Diagnostic Tests
Vaccines and Drugs
h. Malaria
i. Chagas Disease
j. Babesiosis
3. PATHOGEN REDUCTION
4. LEUKOCYTE REDUCTION
Background
Methods
B. Instrumentation Review: Operating Characteristics, Features and Selling Prices of Leading Blood Typing, Grouping and Infectious Disease Screening Automated and Semiautomated Analyzers
C.Major Blood Banking Technologies and Their Potential Applications
1. MOLECULAR DIAGNOSTICS
2. MONOCLONAL AND POLYCLONAL ANTIBODIES
3. IMMUNOASSAYS
4. MICROTITRATION PLATES
5. IT AND AUTOMATION
6. LASERS
7. ROBOTICS
8. SYNTHETIC RED CELL SUBSTITUTES
9. GENETICALLY ENGINEERED BLOOD COMPONENTS
10. BLOOD PRESERVATION
11. AUTOLOGOUS BLOOD TRANSFUSION/FREEZING
VI. UK Blood Banking Market
A. EXECUTIVE SUMMARY
B. Business Environment
C. Market Structure
D. Market Size, Test Volume and Sales Forecasts, by Market Segment,Major Supplier Sales and Market Shares
VII. Competitive Assessments
Abbott
Beckman Coulter/Danaher
Becton Dickinson
Biokit
BioMerieux
Bio-Rad
CellMark Forensics/LabCorp
Diagast
DiaSorin
Fujirebio
Hologic/Gen-Probe
Grifols
Immucor
Ortho-Clinical Diagnostics
Proteome Sciences
Quest Diagnostics
Quidel
Roche
Siemens
Tecan
LIST OF TABLES
Major Companies Developing or Marketing Blood Typing and Grouping Tests
Major Companies Developing or Marketing HLA Typing Tests
Major Companies Developing or Marketing AIDS Tests
Major Companies Developing or Marketing Hepatitis Tests
Major Companies Developing or Marketing CMV Tests
Major Companies Developing or Marketing Syphilis Tests
Major Companies Developing or Marketing Blood Bank Analyzers
Executive Summary Table: U.K., Total Blood Bank Test Volume and Reagent Sales Forecast by Test Category
U.K., Facilities Performing Blood Bank Tests by Market Segment
U.K., Hospital Laboratories Performing Blood Bank Tests by Bed Size
U.K., Commercial/Private Laboratories Performing Blood Bank Tests by Annual Test Volume
U.K., All Market Segments Blood Typing And Grouping Test Volume Forecast by Market Segment
U.K., All Market Segments Blood Typing And Grouping Test Volume Forecast
U.K., Hospital Laboratories Blood Typing and Grouping Test Volume Forecast
U.K., Blood Banks Blood Typing And Grouping Test Volume Forecast
U.K., Commercial/Private Laboratories Blood Typing and Grouping Test Volume Forecast
U.K., All Market Segments Infectious Disease Screening Test Volume Forecast by Market Segment
U.K., All Market Segments Infectious Disease Screening Test Volume Forecast
U.K., Blood Banks Infectious Disease Screening Test Volume Forecast
U.K., Hospital Laboratories Infectious Disease Screening Test Volume Forecast
U.K., Commercial/Private Laboratories Infectious Disease Screening Test Volume Forecast
U.K., All Market Segments Blood Typing And Grouping Reagent Market Forecast By Market Segment
U.K., All Market Segments Blood Typing And Grouping Reagent Market Forecast byMajor Test
U.K., Hospital Laboratories Blood Typing and Grouping Reagent Market Forecast ByMajor Test
U.K., Blood Banks Blood Typing and Grouping Reagent Market Forecast byMajor Test
U.K., All Market Segments Infectious Disease Screening Reagent Market Forecast By Market Segment
U.K., All Market Segments Infectious Disease Screening Reagent Market Forecast Segment By Test
U.K., Blood Banks Infectious Disease Screening Reagent Market Forecast by Test
U.K., Hospital Laboratories Infectious Disease Screening Reagent Market Forecast By Test
U.K., Commercial/Private Laboratories Infectious Disease Screening Reagent Market Forecast by Test
U.K., Major Suppliers of Blood Typing And Grouping Reagents Estimated Sales And Market Shares
U.K., HIV-1/2 Blood Screening Market, Reagent Sales byMajor Supplier
U.K., Hepatitis Blood Screening Market, Reagent Sales byMajor Supplier
U.K., Syphilis Blood Screening Market, Reagent Sales byMajor Supplier
Major Companies Developing or Marketing Blood Typing and Grouping Tests
Major Companies Developing or Marketing HLA Typing Tests
Major Companies Developing or Marketing AIDS Tests
Major Companies Developing or Marketing Hepatitis Tests
Major Companies Developing or Marketing CMV Tests
Major Companies Developing or Marketing Syphilis Tests
Major Companies Developing or Marketing Blood Bank Analyzers
Executive Summary Table: U.K., Total Blood Bank Test Volume and Reagent Sales Forecast by Test Category
U.K., Facilities Performing Blood Bank Tests by Market Segment
U.K., Hospital Laboratories Performing Blood Bank Tests by Bed Size
U.K., Commercial/Private Laboratories Performing Blood Bank Tests by Annual Test Volume
U.K., All Market Segments Blood Typing And Grouping Test Volume Forecast by Market Segment
U.K., All Market Segments Blood Typing And Grouping Test Volume Forecast
U.K., Hospital Laboratories Blood Typing and Grouping Test Volume Forecast
U.K., Blood Banks Blood Typing And Grouping Test Volume Forecast
U.K., Commercial/Private Laboratories Blood Typing and Grouping Test Volume Forecast
U.K., All Market Segments Infectious Disease Screening Test Volume Forecast by Market Segment
U.K., All Market Segments Infectious Disease Screening Test Volume Forecast
U.K., Blood Banks Infectious Disease Screening Test Volume Forecast
U.K., Hospital Laboratories Infectious Disease Screening Test Volume Forecast
U.K., Commercial/Private Laboratories Infectious Disease Screening Test Volume Forecast
U.K., All Market Segments Blood Typing And Grouping Reagent Market Forecast By Market Segment
U.K., All Market Segments Blood Typing And Grouping Reagent Market Forecast byMajor Test
U.K., Hospital Laboratories Blood Typing and Grouping Reagent Market Forecast ByMajor Test
U.K., Blood Banks Blood Typing and Grouping Reagent Market Forecast byMajor Test
U.K., All Market Segments Infectious Disease Screening Reagent Market Forecast By Market Segment
U.K., All Market Segments Infectious Disease Screening Reagent Market Forecast Segment By Test
U.K., Blood Banks Infectious Disease Screening Reagent Market Forecast by Test
U.K., Hospital Laboratories Infectious Disease Screening Reagent Market Forecast By Test
U.K., Commercial/Private Laboratories Infectious Disease Screening Reagent Market Forecast by Test
U.K., Major Suppliers of Blood Typing And Grouping Reagents Estimated Sales And Market Shares
U.K., HIV-1/2 Blood Screening Market, Reagent Sales byMajor Supplier
U.K., Hepatitis Blood Screening Market, Reagent Sales byMajor Supplier
U.K., Syphilis Blood Screening Market, Reagent Sales byMajor Supplier
